Search Results for: Cytarabine

CPX-351

CPX-351, whose proposed brand name is Vyxeos, is an investigational treatment for acute myeloid leukemia (AML), a rapidly progressing blood cancer, that consists of a combination of the chemotherapy drugs cytarabine and daunorubicin encapsulated in a ... Read more